4.4 Article

Development of a heterogeneous phantom to measure range in clinical proton therapy beams

Journal

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.ejmp.2021.11.006

Keywords

Proton therapy; Phantom; Range verification; EBT3 film

Ask authors/readers for more resources

This study investigates the development of a bespoke Range Length Phantom (RaLPh) for independent determination of proton range in tissue. The phantom was tested with different configurations of tissue substitute slabs and was found to provide measurable range differences. Results were validated using Monte Carlo simulations and ionisation chamber measurements. The phantom was assessed as an audit device, but further improvements, such as material density override, are required for it to be effective.
Purpose: In particle therapy, determination of range by measurement or calculation can be a significant source of uncertainty. This work investigates the development of a bespoke Range Length Phantom (RaLPh) to allow independent determination of proton range in tissue. This phantom is intended to be used as an audit device. Method: RaLPh was designed to be compact and allows different configurations of tissue substitute slabs, to facilitate measurement of range using radiochromic film. Fourteen RaLPh configurations were tested, using two types of proton fluence optimised water substitutes, two types of bone substitute, and one lung substitute slabs. These were designed to mimic different complex tissue interfaces. Experiments were performed using a 115 MeV mono-energetic scanning proton beam to investigate the proton range for each configuration. Validation of the measured film ranges was performed via Monte Carlo simulations and ionisation chamber measurements. The phantom was then assessed as an audit device, by comparing film measurements with Treatment Planning System (TPS) predicted ranges. Results: Varying the phantom slab configurations allowed for measurable range differences, and the best combinations of heterogeneous material gave agreement between film and Monte Carlo on average within 0.2% and on average within 0.3% of ionisation chamber measurements. Results against the TPS suggest a material density override is currently required to enable the phantom to be an audit device. Conclusion: This study found that a heterogeneous phantom with radiochromic film can provide range verification as part of a dedicated audit for clinical proton therapy beams.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available